Cargando…

(11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization

The aim of the present study was to evaluate the clinical significance of dual radiotracer studies, (11)C-acetate and (18)F-fluoro-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT), for the prediction of response and recurrence after transarterial chemoembolization (TACE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sohyun, Kim, Tae-Sung, Kang, Se Hun, Kim, Hyun Beom, Park, Joong-Won, Kim, Seok-ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156070/
https://www.ncbi.nlm.nih.gov/pubmed/30212970
http://dx.doi.org/10.1097/MD.0000000000012311
_version_ 1783358026559782912
author Park, Sohyun
Kim, Tae-Sung
Kang, Se Hun
Kim, Hyun Beom
Park, Joong-Won
Kim, Seok-ki
author_facet Park, Sohyun
Kim, Tae-Sung
Kang, Se Hun
Kim, Hyun Beom
Park, Joong-Won
Kim, Seok-ki
author_sort Park, Sohyun
collection PubMed
description The aim of the present study was to evaluate the clinical significance of dual radiotracer studies, (11)C-acetate and (18)F-fluoro-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT), for the prediction of response and recurrence after transarterial chemoembolization (TACE). This study retrospectively included a total 42 hepatoceullar carcinoma (HCC) patients (median age, 59; range, 34–85 years old) who underwent (11)C-acetate and (18)F-FDG PET/CT concurrently. Tumor uptake normalized by liver uptake (TNR; maximum tumor SUV to mean normal liver SUV ratio) was obtained first. Then, FAratio, which is the ratio of (18)F-FDG TNR (TNR_FDG) to (11)C-acetate TNR, was obtained and correlated with response after TACE and recurrence-free survival (RFS), using a Cox multivariate proportional-hazard model. Among clinical factors, including the Hepatoma Arterial Embolization Prognostic score and positron emission tomography (PET) parameters, multiple regression analysis revealed FAratio and tumor size to be the only significant factors. As a PET parameter, FAratio exhibited the largest area under the curve in the prediction of response after TACE. In the Cox multivariate proportional-hazard model, TNR_FDG was the only significant predictive factor for RFS. In subgroup analysis, TNR_FDG was the only significant predictive factor for recurrence in intermediate stage patients. However, FAratio was the only significant predictive factor for recurrence in advanced stage patients. Dual radiotracer use of (11)C-acetate and (18)F-FDG PET/CT contributed to the prediction of response and recurrence after TACE. Used in addition to (18)F-FDG, (11)C-acetate PET/CT could give additional information in advanced stage patients. Based on the characteristics of tumor metabolism assessed by dual radiotracer PET/CT, treatment plans could be more personalized and optimized.
format Online
Article
Text
id pubmed-6156070
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-61560702018-11-08 (11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization Park, Sohyun Kim, Tae-Sung Kang, Se Hun Kim, Hyun Beom Park, Joong-Won Kim, Seok-ki Medicine (Baltimore) Research Article The aim of the present study was to evaluate the clinical significance of dual radiotracer studies, (11)C-acetate and (18)F-fluoro-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT), for the prediction of response and recurrence after transarterial chemoembolization (TACE). This study retrospectively included a total 42 hepatoceullar carcinoma (HCC) patients (median age, 59; range, 34–85 years old) who underwent (11)C-acetate and (18)F-FDG PET/CT concurrently. Tumor uptake normalized by liver uptake (TNR; maximum tumor SUV to mean normal liver SUV ratio) was obtained first. Then, FAratio, which is the ratio of (18)F-FDG TNR (TNR_FDG) to (11)C-acetate TNR, was obtained and correlated with response after TACE and recurrence-free survival (RFS), using a Cox multivariate proportional-hazard model. Among clinical factors, including the Hepatoma Arterial Embolization Prognostic score and positron emission tomography (PET) parameters, multiple regression analysis revealed FAratio and tumor size to be the only significant factors. As a PET parameter, FAratio exhibited the largest area under the curve in the prediction of response after TACE. In the Cox multivariate proportional-hazard model, TNR_FDG was the only significant predictive factor for RFS. In subgroup analysis, TNR_FDG was the only significant predictive factor for recurrence in intermediate stage patients. However, FAratio was the only significant predictive factor for recurrence in advanced stage patients. Dual radiotracer use of (11)C-acetate and (18)F-FDG PET/CT contributed to the prediction of response and recurrence after TACE. Used in addition to (18)F-FDG, (11)C-acetate PET/CT could give additional information in advanced stage patients. Based on the characteristics of tumor metabolism assessed by dual radiotracer PET/CT, treatment plans could be more personalized and optimized. Wolters Kluwer Health 2018-09-14 /pmc/articles/PMC6156070/ /pubmed/30212970 http://dx.doi.org/10.1097/MD.0000000000012311 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Park, Sohyun
Kim, Tae-Sung
Kang, Se Hun
Kim, Hyun Beom
Park, Joong-Won
Kim, Seok-ki
(11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
title (11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
title_full (11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
title_fullStr (11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
title_full_unstemmed (11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
title_short (11)C-acetate and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
title_sort (11)c-acetate and (18)f-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156070/
https://www.ncbi.nlm.nih.gov/pubmed/30212970
http://dx.doi.org/10.1097/MD.0000000000012311
work_keys_str_mv AT parksohyun 11cacetateand18ffluorodeoxyglucosepositronemissiontomographycomputedtomographydualimagingforthepredictionofresponseandprognosisaftertransarterialchemoembolization
AT kimtaesung 11cacetateand18ffluorodeoxyglucosepositronemissiontomographycomputedtomographydualimagingforthepredictionofresponseandprognosisaftertransarterialchemoembolization
AT kangsehun 11cacetateand18ffluorodeoxyglucosepositronemissiontomographycomputedtomographydualimagingforthepredictionofresponseandprognosisaftertransarterialchemoembolization
AT kimhyunbeom 11cacetateand18ffluorodeoxyglucosepositronemissiontomographycomputedtomographydualimagingforthepredictionofresponseandprognosisaftertransarterialchemoembolization
AT parkjoongwon 11cacetateand18ffluorodeoxyglucosepositronemissiontomographycomputedtomographydualimagingforthepredictionofresponseandprognosisaftertransarterialchemoembolization
AT kimseokki 11cacetateand18ffluorodeoxyglucosepositronemissiontomographycomputedtomographydualimagingforthepredictionofresponseandprognosisaftertransarterialchemoembolization